Haplotype diversity of Plasmodium falciparum circumsporozoite protein prior to malaria vaccine implementation in Kaelé Health District, Cameroon, 2022–2023
Carolina Digital Repository (University of North Carolina at Chapel Hill) · 16.06.2026
DOI: 10.17615/qmbq-ga28 ↗Kurz gefasst
Fachartikel in der Zeitschrift Carolina Digital Repository (University of North Carolina at Chapel Hill), erschienen am 16.06.2026. Verfasst von Innocent M. Ali und 13 weiteren Autor:innen.
Abstract (Originalsprache)
Malaria remains a major public health concern in Cameroon, with Plasmodium falciparum responsible for most morbidity and mortality, particularly among children under five. In response to rising cases, Cameroon began implementing the RTS,S/AS01 malaria vaccine in early 2024. Given the vaccine’s strain-specific efficacy, understanding haplotypic diversity is critical for evaluating long-term impact. We analyzed 100 P. falciparum-positive dried blood spots collected in Mapoussere, Kaele Health District (2022–2023). Using the 4CAST amplicon sequencing assay, we targeted four genes: csp (circumsporozoite protein), ama1 (apical membrane antigen 1), sera2 (serine repeat antigen 2), and trap (thrombospondin-related anonymous protein). Haplotypes were identified using SeekDeep, and diversity metrics including heterozygosity (He), nucleotide diversity (π), and selection statistics (Tajima’s D, Fu and Li’s D*, F*) were computed. We successfully genotyped csp in 35% of samples, identifying 22 haplotypes (He = 0.908; π = 0.021). The vaccine-matched haplotype was present in 20% of genotyped infections. The T cell TH2 and TH3 epitopes of csp showed signs consistent with balancing selection. Both ama1 and sera2 exhibited higher genotyping success and diversity, with ama showing significant Tajima’s D values. Within-participant haplotype counts were highest for ama1 (mean = 2.8), followed by sera2 (2.1), csp (1.3), and trap (1.2). This study provides a baseline of P. falciparum haplotype diversity in a vaccine-targeted region. The presence of vaccine-matched strains and high diversity in TH2/TH3 epitopes in csp may influence vaccine efficacy. Continued molecular surveillance is essential to monitor antigenic shifts and guide future strategies.
Schlagwörter
Zitieren
APA
Ali, I. M., Wanda, G. Y., Tchuenkam, V. P. K., Bailey, J. A., Nsango, S. E., Lin, J. T., Gorman, C., C., Sadler, J. M., Dinglasan, R. R., Junior, V. V., Juliano, J. J., Ateba, J. M., & Martinez, B. V. (2026). Haplotype diversity of Plasmodium falciparum circumsporozoite protein prior to malaria vaccine implementation in Kaelé Health District, Cameroon, 2022–2023. Carolina Digital Repository (University of North Carolina at Chapel Hill). https://doi.org/10.17615/qmbq-ga28
Vancouver
Ali IM, Wanda GY, Tchuenkam VPK, Bailey JA, Nsango SE, Lin JT, et al. Haplotype diversity of Plasmodium falciparum circumsporozoite protein prior to malaria vaccine implementation in Kaelé Health District, Cameroon, 2022–2023. Carolina Digital Repository (University of North Carolina at Chapel Hill). 2026. doi:10.17615/qmbq-ga28
BibTeX
@article{Ali2026,
author = {Ali, Innocent M. and Wanda, Grace Yimga and Tchuenkam, Valery P. K. and Bailey, Jeffrey A. and Nsango, Sandrine E. and Lin, Jessica T. and Gorman and C., Catherine and Sadler, Jacob M. and Dinglasan, Rhoel R. and Junior, Voundi V and Juliano, Jonathan J. and Ateba, Joël Marcellin and Martinez, Brenda Vasquez},
title = {Haplotype diversity of Plasmodium falciparum circumsporozoite protein prior to malaria vaccine implementation in Kaelé Health District, Cameroon, 2022–2023},
journal = {Carolina Digital Repository (University of North Carolina at Chapel Hill)},
year = {2026},
doi = {10.17615/qmbq-ga28}
}
EUVIMED